Interventional, Randomised, Double-blind, Parallel-group, Active-comparator, Flexible-dose Study to Compare the Effectiveness of Brexpiprazole to That of Risperidone in Adult Patients With Schizophrenia

Trial Profile

Interventional, Randomised, Double-blind, Parallel-group, Active-comparator, Flexible-dose Study to Compare the Effectiveness of Brexpiprazole to That of Risperidone in Adult Patients With Schizophrenia

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 03 Aug 2016

At a glance

  • Drugs Brexpiprazole (Primary) ; Risperidone (Primary)
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Acronyms TAILWIND
  • Sponsors Lundbeck A/S
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 03 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top